Anti Mullerian Hormone (AMH): Introduction
- The anti-Müllerian hormone (AMH) is a glycoprotein-based hormone that is used to determine fertility levels
- The anti-Mullerian hormone (AMH) test measures the level of anti-müllerian hormone (AMH) in the blood. AMH is produced in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on the patient’s age and gender.
- In females, the roles of the AMH have been the focus of recent attention. AMH plays an important role in the development of sex organs in an unborn baby. In women, the anti-Müllerian hormone test is employed to assess ovarian function and menopausal status; in the evaluation of polycystic ovary syndrome (PCOS) or to evaluate the effectiveness of ovarian cancer treatment. The AMH test is also used to evaluate the presence of external sex organs that are not clearly male or female infants (ambiguous genitalia) and/or function of the testicles in an infant boy.
To gauge the scope of customization in our reports, Ask for a Sample
Key Drivers and Restraints of Global Anti Mullerian Hormone (AMH) testing Market
- Presently, women have come a long way in terms of their careers and social standing. However, a majority of them are still unaware about their personal well-being and health needs. Government initiatives have changed the entire scenario.
- On October 18, 2014, the International IMS Society celebrated 'World Menopause Day' with the theme 'Prevention of diseases after menopause'. Rise in initiatives toward women’s education and awareness about their health is likely to generate high demand for diagnostic products including AMH testing.
- Incidence of women’s health diseases is increasing across the world. According to the Global Burden of Disease Study 2013 (GBD 2013), acute and chronic diseases and injuries occurred in 188 countries between 1990 and 2013 showed the following results: For uterine fibroid, 105,090 (*1000) cases were observed in 1990. The number increased to 171,005 (*1000) in 2013. Moreover, for polycystic ovarian syndrome, the number of cases increased from 80,815 in 1990 to 122,311 (*1000) in 2013.
Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report
Polycystic Ovary Syndrome (PCOS) Evaluation to Lead Global Market
- The global anti-Mullerian hormone (AMH) testing market can be segmented based on application, end-user, and region
- In terms of application, the global anti-Mullerian hormone (AMH) testing market can be divided into ovarian function, menopausal status, evaluation of polycystic ovary syndrome (PCOS), ovarian cancer treatment, and others
- Based on end-user, the global anti-Mullerian hormone (AMH) testing market can be categorized into hospitals, diagnostic laboratories, and others
Asia Pacific to be Lucrative Market
- The global anti-Mullerian hormone (AMH) testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominates the global-anti Mullerian hormone (AMH) testing market. Advancements in diagnostics, rise in awareness about effective use of AMH testing, and favorable reimbursement policies are key factors that make North America a highly attractive market among all regions. Asia Pacific is a highly populated region in the world. This offers significant opportunities for market players to expand their business in the region. Hence, existing global as well as local and regional players have a great scope to focus on this region in order to expand their business.
Key Players Operating in Global Anti Mullerian Hormone (AMH) testing Market
Leading players in the global anti-Mullerian hormone (AMH) testing market are:
- Danaher Corporation
- Becton, Dickinson and Company
Global Anti Mullerian Hormone (AMH) testing Market: Research Scope
Global Anti Mullerian Hormone (AMH) testing Market, by Application
- Ovarian Function
- Menopausal Status
- Evaluation Of Polycystic Ovary Syndrome (PCOS)
- Ovarian Cancer Treatment
Global Anti Mullerian Hormone (AMH) testing Market, by End-user
- Diagnostic Laboratories
Global Anti Mullerian Hormone (AMH) testing Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.